&;AElig;terna Zentaris to Announce Third Quarter 2009 Financial and Operating Results on November 11, 2009

Show Health and Fitness Publications

Tue, November 10, 2009

[ Tue, Nov 10th 2009 ]: Market Wire

Premium Brands Holdings Corporation Announces 2009 Third Quarter Results Including Record EBITDA

[ Tue, Nov 10th 2009 ]: Market Wire

Auxilium Pharmaceuticals to Present at the Credit Suisse 18th Annual Global Healthcare Conference

[ Tue, Nov 10th 2009 ]: Market Wire

Dynavax to Acquire Symphony Dynamo, Inc., Including $20 Million in Unrestricted Cash

[ Tue, Nov 10th 2009 ]: Market Wire

Appointment of Hans Mader to the Sernova Business Advisory Board

Mon, November 9, 2009

[ Mon, Nov 09th 2009 ]: Market Wire

Cytokinetics Announces Advancement of CK-2017357 in Phase I Clinical Trials

[ Mon, Nov 09th 2009 ]: Market Wire

Adeona Launches CopperProof Test Panel

[ Mon, Nov 09th 2009 ]: Market Wire

Angiotech Pharmaceuticals, Inc. announces financi .. ts for the third quarter ended September 30, 2009

[ Mon, Nov 09th 2009 ]: Market Wire

SciClone Reports Financial Results and Provides C .. nd Pipeline Updates for the Third Quarter of 2009

[ Mon, Nov 09th 2009 ]: Market Wire

&;AElig;terna Zentaris: Scientific Article Supports Perifosine';s Development in Kidney Cancer

[ Mon, Nov 09th 2009 ]: Market Wire

Cypress Bioscience Announces Third Quarter 2009 Financial Results

[ Mon, Nov 09th 2009 ]: Market Wire

Syneron Reports Third Quarter 2009 Financial Results

Fri, November 6, 2009

[ Fri, Nov 06th 2009 ]: Market Wire

Cardiome to Release Third Quarter Results

[ Fri, Nov 06th 2009 ]: Market Wire

Hypertension Diagnostics Announces First Quarter Fiscal Year 2010 Results

[ Fri, Nov 06th 2009 ]: Market Wire

Stellar Pharmaceuticals' Q3-2009 Financial Result .. rked by Strong Growth and Continued Profitability

[ Fri, Nov 06th 2009 ]: Market Wire

Oncolytics Biotech(R) Inc. Collaborators Present .. e II Sarcoma Trial Results at CTOS Annual Meeting

[ Fri, Nov 06th 2009 ]: Market Wire

First Transcatheter Valve Cases in Japan Performed With Edwards SAPIEN Valve

[ Fri, Nov 06th 2009 ]: Market Wire

Metro One Development Prepares for Ad Sales

[ Fri, Nov 06th 2009 ]: Market Wire

Agennix AG Shares Begin Trading on Frankfurt Stock Exchange

Thu, November 5, 2009

[ Thu, Nov 05th 2009 ]: Market Wire

Centric Health reports solid 2009 third quarter financial results

[ Thu, Nov 05th 2009 ]: Market Wire

Theravance and Astellas Announce the Commercial L .. of VIBATIV(TM) (telavancin) in the United States

[ Thu, Nov 05th 2009 ]: Market Wire

DIAGNOS Announces the Sale of the Harricana North Property to North American Palladium Ltd

[ Thu, Nov 05th 2009 ]: Market Wire

Oncolytics Biotech(R) Inc. Announces 2009 Third Quarter Results

Wed, November 4, 2009

[ Wed, Nov 04th 2009 ]: Market Wire

Leatt Corporation Wins 2009 Product Innovation Award From Freeride Magazine

[ Wed, Nov 04th 2009 ]: Market Wire

Meridian Medical Sales Distribution Expands in Key East Coast Markets

[ Wed, Nov 04th 2009 ]: Market Wire

Northstar Healthcare Announces Complete Resolution to Dispute with Major Payor

[ Wed, Nov 04th 2009 ]: Market Wire

Remedent to Present FirstFit, a Revolutionary Sol .. owns, at the Den-Mat Education Destination Semina

[ Wed, Nov 04th 2009 ]: Market Wire

ImmuCell Announces Financial Results for Third Quarter of 2009

[ Wed, Nov 04th 2009 ]: Market Wire

&;AElig;terna Zentaris to Announce Third Quarter .. ancial and Operating Results on November 11, 2009

[ Wed, Nov 04th 2009 ]: Market Wire

Cipher reports Q3 2009 financial results

Tue, November 3, 2009

[ Tue, Nov 03rd 2009 ]: Market Wire

BIOLASE Introduces the Diolase 10(TM) Diode Laser for Pain Management, Therapeutic Applications

[ Tue, Nov 03rd 2009 ]: Market Wire

Stem Cell Therapy International, Inc. and Histostem Korea Announce $5 Million Financing Commitment

[ Tue, Nov 03rd 2009 ]: Market Wire

Oncolytics Biotech(R) Inc. Announces Results of Second Warrant Expiry Date Acceleration Program

[ Tue, Nov 03rd 2009 ]: Market Wire

MDS Inc. and Danaher Corporation Receive Second R .. .S. Federal Trade Commission for MDS Analytical T

[ Tue, Nov 03rd 2009 ]: Market Wire

SciClone Pharmaceuticals to Present at Two November Investor Conferences

[ Tue, Nov 03rd 2009 ]: Market Wire

Reflect Scientific Consolidates Cryometrix Product Line to Montana Facility

Mon, November 2, 2009

[ Mon, Nov 02nd 2009 ]: Market Wire

Adeona Receives IRB Approval to Initiate Clinical .. -Daily Oral Zinthionein ZC in Alzheimer's Disease

[ Mon, Nov 02nd 2009 ]: Market Wire

InternetArray Launches PremierGoldTraders.com

[ Mon, Nov 02nd 2009 ]: Market Wire

Media Advisory - Oncolytics Biotech(R) Inc. to Present at BIO-Europe 2009

[ Mon, Nov 02nd 2009 ]: Market Wire

Auxilium Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference

[ Mon, Nov 02nd 2009 ]: Market Wire

Sernova Closes First Tranche of Private Placement .. nt of Dr. Annemarie Moseley to Board of Directors

[ Mon, Nov 02nd 2009 ]: Market Wire

Flutiform EU Clinical Trial Successfully Completed

Sun, November 1, 2009

[ Sun, Nov 01st 2009 ]: Market Wire

Human Genome Sciences and GlaxoSmithKline Announc .. of Two Phase 3 Trials of BENLYSTA(TM) in Systemic

Fri, October 30, 2009

[ Fri, Oct 30th 2009 ]: Market Wire

Novo Nordisk A/S: Novo Nordisk A/S: Director/PDMR Shareholding

[ Fri, Oct 30th 2009 ]: Market Wire

Sierra Geothermal Awarded US$10 Million of DOE Grants

[ Fri, Oct 30th 2009 ]: Market Wire

MMR Information Systems' Medical Advisor Dr. Arno .. W. Klein Authors Guide on Personal Health Records

[ Fri, Oct 30th 2009 ]: Market Wire

Cypress Bioscience, Inc. to Present at Oppenheimer 20th Annual Healthcare Conference

[ Fri, Oct 30th 2009 ]: Market Wire

Oncolytics Biotech(R) Inc. Collaborators to Prese .. e II Sarcoma Trial Results at CTOS Annual Meeting

[ Fri, Oct 30th 2009 ]: Market Wire

SemBioSys enters in non-dilutive financing plan of arrangement

&;AElig;terna Zentaris to Announce Third Quarter 2009 Financial and Operating Results on November 11, 2009

//health-fitness.news-articles.net/content/2009/ .. l-and-operating-results-on-november-11-2009.html

Published in Health and Fitness on Wednesday, November 4th 2009 at 4:05 GMT by Market Wire
^{🞛 This publication is a summary or evaluation of another publication}

QUÉBEC CITY, Nov. 4 /CNW Telbec/ - Æterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, will announce its third quarter 2009 financial and operating results before market open on Wednesday, November 11, 2009. The Company will host a conference call and webcast to discuss these results later that same day at 10:00 a.m., Eastern Time.

Participants may access the live webcast via the Company's website at [ www.aezsinc.com ] in the "Investors" section, or by telephone using the following numbers: 877-974-0453, 416-644-3431, or 514-227-8860. A replay of the webcast will also be available on the Company's website for a period of 30 days.

About Æterna Zentaris Inc.

Æterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at [ www.aezsinc.com ].